Overview

Albumin-bound Paclitaxel Combination With Capecitabine Versus Capecitabine Monotherapy in Paclitaxel/Docetaxel-resistant Advanced Breast Cancer

Status:
Recruiting
Trial end date:
2023-02-25
Target enrollment:
Participant gender:
Summary
Albumin-bound Paclitaxel Combination With Capecitabine Versus Capecitabine Monotherapy in Paclitaxel/Docetaxel-resistant Advanced Breast Cancer
Phase:
Phase 2
Details
Lead Sponsor:
Fudan University
Treatments:
Albumin-Bound Paclitaxel
Capecitabine
Paclitaxel